QQ客服 官方微博 反馈留言

	A novel anticancer agent, retigeric acid B, displays proliferation inhibition, S phase arrest and apoptosis activation in human prostate cancer cells.
	Liu H; Liu YQ; Xu AH; Young CY; Yuan HQ; Lou HX
刊名	Chemico-biological interactions
	2010
卷号	188期号:3页码:598-606
关键词	Retigeric acid B PC-3 LNCaP Cell cycle Apoptosis
DOI	10.1016/j.cbi.2010.07.024
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5501695
专题	山东大学
作者单位	1.Institute of Biochemistry and Molecular Biology, School of Medicine, Shandong University, 44 Wenhua westroad, Jinan 250012, China 2.[ Liu, Y.-Q
推荐引用方式 GB/T 7714	Liu H,Liu YQ,Xu AH,et al. A novel anticancer agent, retigeric acid B, displays proliferation inhibition, S phase arrest and apoptosis activation in human prostate cancer cells.[J]. Chemico-biological interactions,2010,188(3):598-606.
APA	Liu H,Liu YQ,Xu AH,Young CY,Yuan HQ,&Lou HX.(2010).A novel anticancer agent, retigeric acid B, displays proliferation inhibition, S phase arrest and apoptosis activation in human prostate cancer cells..Chemico-biological interactions,188(3),598-606.
MLA	Liu H,et al."A novel anticancer agent, retigeric acid B, displays proliferation inhibition, S phase arrest and apoptosis activation in human prostate cancer cells.".Chemico-biological interactions 188.3(2010):598-606.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。